BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24492222)

  • 1. [Front line of combating counterfeit medicines, globally and locally].
    Kimura K
    Yakugaku Zasshi; 2014; 134(2):195-6. PubMed ID: 24492222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-counterfeit activities of pharmaceutical companies in Japan: for patient safety].
    Shofuda K; Aragane K; Igari Y; Matsumoto K; Ito K
    Yakugaku Zasshi; 2014; 134(2):203-11. PubMed ID: 24492224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating counterfeit medicines and illicit trade in tobacco products: minefields in global health governance.
    Liberman J
    J Law Med Ethics; 2012; 40(2):326-47. PubMed ID: 22789049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Counterfeit medications and their negative impacts on health care.
    Fincham JE
    Am J Pharm Educ; 2014 Apr; 78(3):48. PubMed ID: 24761009
    [No Abstract]   [Full Text] [Related]  

  • 6. [The role of German official medicines control laboratories in combating counterfeit medicines].
    Wiegard A; Heuermann M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1214-1220. PubMed ID: 28948293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
    Kumar B; Baldi A
    Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.
    Mackey TK; Liang BA
    BMC Med; 2013 Oct; 11():233. PubMed ID: 24228892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Counterfeit and contraband drugs in Brazil: overview and prospects for preventing their use].
    Hurtado RL; Lasmar MC
    Cad Saude Publica; 2014 Apr; 30(4):891-5. PubMed ID: 24896066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROLE OF THE INTERNATIONAL ORGANIZATIONS IN PREVENTING THE COUNTERFEIT MEDICINES ENTRY INTO THE WORLD MARKETS.
    Stukina V; Dohnal J; Saloun J
    Acta Pol Pharm; 2016 Sep; 73(5):1381-1388. PubMed ID: 29638079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. After counterfeit Avastin®--what have we learned and what can be done?
    Mackey TK; Cuomo R; Guerra C; Liang BA
    Nat Rev Clin Oncol; 2015 May; 12(5):302-8. PubMed ID: 25734637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [European Network of Official Medicines Control Laboratories : International OMCL Working Group Combating Counterfeit and other Illegal Medicines].
    Wanko R; Unkelbach U
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1221-1227. PubMed ID: 28921172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legal aspects of counteracting the trafficking of falsified medicines in the european union.
    Pashkov V; Soloviov A; Olefir A
    Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Governments pledge to clamp down on counterfeit drugs.
    Watson R
    BMJ; 2011 Nov; 343():d7096. PubMed ID: 22045993
    [No Abstract]   [Full Text] [Related]  

  • 16. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 17. Counterfeit drugs pose growing health threat.
    Traynor K
    Am J Health Syst Pharm; 2010 Nov; 67(22):1896, 1898. PubMed ID: 21048204
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Working Group of Enforcement Officers (WGEO) : The European Network of Drug Regulatory Authorities to Combat Pharmaceutical Crime].
    Wittstock M; Streit R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Nov; 60(11):1228-1232. PubMed ID: 28980025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding and fighting the medicine counterfeit market.
    DĂ©gardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Campaign against counterfeit drugs].
    Warnet S
    Rev Infirm; 2013; (193):8. PubMed ID: 24245394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.